Highlights and Quick Summary
- Repayment/Issuance of Debt (Net) for the quarter ending June 30, 2023 was $-496 Million (a 5807.14% increase compared to previous quarter)
- Year-over-year quarterly Repayment/Issuance of Debt (Net) decreased by -316.11%
- Annual Repayment/Issuance of Debt (Net) for 2022 was $564 Million (a -1671.59% decrease from previous year)
- Annual Repayment/Issuance of Debt (Net) for 2021 was $-35.9 Million (a -157.07% decrease from previous year)
- Annual Repayment/Issuance of Debt (Net) for 2020 was $62.9 Million (a 359.12% increase from previous year)
- Twelve month Repayment/Issuance of Debt (Net) ending June 30, 2023 was $76.5 Million (a -86.44% decrease compared to previous quarter)
- Twelve month trailing Repayment/Issuance of Debt (Net) decreased by -62.56% year-over-year
Trailing Repayment/Issuance of Debt (Net) for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $76.5 Million | $564 Million | $564 Million | $204 Million |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Repayment/Issuance of Debt (Net) of Emergent Biosolutions Inc.
Most recent Repayment/Issuance of Debt (Net)of EBS including historical data for past 10 years.Interactive Chart of Repayment/Issuance of Debt (Net) of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Repayment/Issuance of Debt (Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-496.2 | $-8.4 | – | – | – |
| 2022 | $351.5 | $229.6 | $-8.4 | $-8.5 | $564.2 |
| 2021 | $-8.4 | $-5.6 | $-5.7 | $-16.2 | $-35.9 |
| 2020 | $-5.7 | $94.2 | $-2.8 | $-22.8 | $62.9 |
| 2019 | $-12.9 | $-17.8 | $97.2 | $-52.8 | $13.7 |
| 2018 | – | – | – | $795.2 | $795.2 |
| 2017 | – | – | – | $-20.0 | $-20.0 |
| 2015 | – | $0.0 | $0.0 | $2.0 | $2.0 |
| 2014 | $-0.07 | $0.0 | $0.0 | $180.65 | $180.59 |
| 2013 | $2.58 | $-1.12 | $-1.12 | $-1.12 | $-0.77 |
| 2012 | $-0.24 | $0.82 | – | – | $3.32 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic